Date published: 2026-5-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

MFSD7 Inhibitors

MFSD7 inhibitors comprise a diverse array of compounds, each selected for their ability to modulate the activity of the MFSD7 protein. This class is characterized by its shared objective of influencing MFSD7's role in cellular transport mechanisms, rather than by a uniform chemical structure. The inhibitors within this class operate through a variety of mechanisms, each tailored to interact with different stages of the transport and signaling processes in which MFSD7 is involved. Their modes of action reflect the intricacy of solute carrier proteins' functions, which are crucial for maintaining cellular homeostasis, nutrient uptake, and waste removal. The primary approach of these inhibitors is to indirectly disrupt or modify the transport activity of MFSD7. This disruption can occur through several pathways, including altering ion gradients across the cell membrane, which are fundamental to the transport mechanisms of many solute carriers. By targeting key components such as ion channels or enzymes involved in maintaining these gradients, the inhibitors can change the electrochemical environment, affecting MFSD7's ability to transport its substrates. Additionally, some inhibitors in this class focus on modulating intracellular signaling pathways that are intricately linked to the transport activities of solute carriers. By influencing these signaling cascades, the inhibitors can indirectly impact the regulation and function of MFSD7. The MFSD7 Inhibitors class exemplifies a strategic approach to manipulating a specific protein's function by intervening in broader biological processes. This class underscores the complex interplay between chemical entities and biological systems, highlighting the depth of understanding required to effectively manipulate protein functions within intricate cellular networks. It represents a sophisticated avenue of research that focuses on modulating the activity of transmembrane transporters, demonstrating the potential of indirect inhibition as a means to influence specific protein activities within the cell. By concentrating on the modulation of transport proteins and their associated pathways, these inhibitors offer insights into the mechanisms of cellular transport and homeostasis, shedding light on the role of proteins like MFSD7 in these vital processes.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Amiloride

2609-46-3sc-337527
1 g
$296.00
7
(1)

Amiloride could affect MFSD7 indirectly by altering sodium ion gradients, potentially influencing MFSD7's transport activity.

Ouabain-d3 (Major)

sc-478417
1 mg
$516.00
(0)

Ouabain inhibits Na+/K+ ATPase, which might change ion gradients and indirectly affect the function of MFSD7 by altering the electrochemical conditions.

Probenecid

57-66-9sc-202773
sc-202773A
sc-202773B
sc-202773C
1 g
5 g
25 g
100 g
$28.00
$39.00
$100.00
$277.00
28
(2)

Probenecid inhibits organic anion transporters and might indirectly influence MFSD7 if its function involves similar substrate types or transport mechanisms.

Indomethacin

53-86-1sc-200503
sc-200503A
1 g
5 g
$29.00
$38.00
18
(1)

Indomethacin, by inhibiting cyclooxygenase, could alter cellular processes and indirectly affect MFSD7's function in solute transport.

Niflumic acid

4394-00-7sc-204820
5 g
$32.00
3
(1)

Niflumic Acid could indirectly affect MFSD7 by blocking chloride channels, influencing ion gradients and transport activity.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin increases cAMP levels, potentially modulating signaling pathways that could indirectly affect the activity of MFSD7.

Quinidine

56-54-2sc-212614
10 g
$104.00
3
(1)

Quinidine blocks potassium channels, potentially altering ion gradients and indirectly affecting MFSD7's transport function.

Nitrendipine

39562-70-4sc-201466
sc-201466A
sc-201466B
50 mg
100 mg
500 mg
$109.00
$160.00
$458.00
6
(1)

Nitrendipine, by blocking calcium channels, could indirectly influence the activity of MFSD7 through altered calcium ion gradients.

Furosemide

54-31-9sc-203961
50 mg
$41.00
(1)

Furosemide inhibits the Na-K-Cl cotransporter, potentially affecting ion homeostasis and indirectly influencing MFSD7's function.

Losartan

114798-26-4sc-353662
100 mg
$130.00
18
(1)

Losartan might indirectly affect MFSD7 by altering angiotensin II-mediated cellular processes, potentially impacting ion transport and MFSD7 activity.